Nouvelles cliniques Nantaises

Nantes 44277

0 studies enrolling now · 14 studies all time

What they study most

Acute Coronary Syndrome (ACS), Brady Tachy Syndrome, CIED Related Infection, Cardiovascular Disease, Coronary Artery Disease, Coronary Atherosclerosis, Heart Failure, Heart Failure NYHA Class III and Ambulatory IV, Heart Failure With Left Bundle Branch Block, Hyperlipidemia, Sinus Node Dysfunction, Ventricular Tachycardia

Studies at this site

• Personalized Therapy Study - Attain Stability Quad Post-Approval Study — Running, not enrolling
• Personalized Therapy Study - Intrinsic Antitachycardia Pacing Post-Approval Study (iATP PAS) — Running, not enrolling
• Bifurcation Lesion Analysis and STenting / BLAST — Completed
• AdaptResponse Clinical Trial — Completed
• MOre REsponse on Cardiac Resynchronization Therapy With MultiPoint Pacing — Stopped early
• Personalized CRT - MPP Post Approval Study — Completed
• World-wide Randomized Antibiotic Envelope Infection Prevention Trial — Completed
• The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early
• Clinical Trial of the SonRtip Lead and Automatic AV-VV Optimization Algorithm in the PARADYM RF SonR CRT-D — Status unconfirmed
• Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events — Completed
• The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early
• The Dual Antiplatelet Therapy Study (DAPT Study) — Completed
• A Study Assessing the REG1 Anticoagulation System Compared Heparin in Subjects With Acute Coronary Syndrome — Completed
• Prevention of Atrial Arrhythmia in Patients Without Atrioventricular (AV) Conduction Disease — Completed